Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any early-onset non-syndromic cataract in which the cause of the disease is a mutation in the MIP gene.
Features include very common findings: Lamellar cataract; and sometimes findings: Cortical cataract. 3 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 3 | Nuclear cataract, Cortical cataract, Lamellar cataract |
MIP encodes major intrinsic protein of lens fiber (263 aa). Aquaporins form homotetrameric transmembrane channels, with each monomer independently mediating water transport across the plasma membrane along its osmotic gradient. Highest expression in Testis (2.1 TPM) and Liver (0.5 TPM).
Cataract 15 multiple types is associated with mutations in the MIP gene on chromosome 12.
The MIP protein participates in TRIP11:IFT20 dissociates, IL10 negatively regulates extracellular inflammatory mediators, and TBX21 positively regulates expression of C-C motif chemokine 3 (CCL3) pathways.
MIP is classified as a druggable target (Druggable Genome, Ion Channel, and Protease categories) with score 0.0.
Genetic testing for MIP is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 1 very common feature.
No clinical trials have been registered for cataract 15 multiple types.
9 publications have been identified in PubMed for cataract 15 multiple types. Research spans Review / Meta-Analysis (22%), Clinical Trial Publication (22%), and Epidemiology / Natural History (22%).
Hao C (2025). [PMID: 40183733](https://pubmed.ncbi.nlm.nih.gov/40183733/). *Invest Ophthalmol Vis Sci*. [Epidemiology / Natural History]
de Jong B (2025). [PMID: 41424410](https://pubmed.ncbi.nlm.nih.gov/41424410/). *Curr Eye Res*. [Clinical Trial Publication]
Chaar DL (2025). [PMID: 40801674](https://pubmed.ncbi.nlm.nih.gov/40801674/). *Invest Ophthalmol Vis Sci*. [Gene Therapy / Novel Therapeutics]
Bartek V (2025). [PMID: 41462830](https://pubmed.ncbi.nlm.nih.gov/41462830/). *Children (Basel)*. [Epidemiology / Natural History]
Cavaleri J (2025). [PMID: 41300177](https://pubmed.ncbi.nlm.nih.gov/41300177/). *Brain Sci*. [Review / Meta-Analysis]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 1:53 PM UTC
Online Mendelian Inheritance in Man
Common questions about cataract 15 multiple types
Camerino M (2024). [PMID: 38643244](https://pubmed.ncbi.nlm.nih.gov/38643244/). *Epigenetics Chromatin*. [Basic Science / Preclinical]
Shiels A (2024). [PMID: 38927721](https://pubmed.ncbi.nlm.nih.gov/38927721/). *Genes (Basel)*. [Review / Meta-Analysis]
Wang MY (2024). [PMID: 39648025](https://pubmed.ncbi.nlm.nih.gov/39648025/). *Zhonghua Yan Ke Za Zhi*. [Clinical Trial Publication]